Summary
Learn more about how PRA worked with a sponsor to create higher enrollment rates and more extensive country selection. Discover how they did this by leveraging our data intelligence and amending the protocol to align inclusion/exclusion criteria.
Register to download
Leveraging Immuno-Oncology Real World Data to Amend Non-Small Cell Lung Cancer Study Design
You may also be interested in:
Blog
Virtual Technology Strives to Make Better Research and Treatments for All
The use of virtual reality (VR) technology, wearable technology, and virtual clinical trials can provide researchers with a more convenient way to…
Read Story
Case Study
Meeting Enrollment Goals Breast Cancer
An open-label, randomized, multi-center study to evaluate the use of Study Drug in the prevention of cancer treatment-related bone loss in…
View Resource
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 1
As the oncology environment continues to grow towards more targeted therapies, it is imperative that patient recruitment strategies focus on how to…
View Resource
View all related content and resources for Oncology
Explore Insights